Phase II Study of Gemcitabine/Vinorelbine vs Sequential Gemcitabine Followed by Vinorelbine in Metastatic Breast Cancer

NCT00532623 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

82

Enrollment

OTHER_GOV

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Gemcitabine plus Vinorelbine
DRUG: Sequential

Sponsor

National Cancer Center, Korea